A Phase 4 interventional study of behavioral intervention in Dental Caries, sponsored by Medical Corps, Israel Defense Force. Status unknown at 1 site in Israel. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-06-29.
Sponsored by Medical Corps, Israel Defense Force · Phase 4, Interventional, and Treatment
Our study is designed as an interventional prospective longitudinal study which examines the Israeli defense force personnel. The population of our study is composed out of the IDF personnel which will be randomly be subdivided into 2 different groups - one will be noted as the intervention group and the other will function as a control group. Each participant will be monitored for a period of 18 months.
On the intervention group, which includes a couple of hundreds participants, a thorough caries management by risk assessment plan will be conducted. The risk assessment will include the following criteria:
After obtaining the data the patients will be categorized into 1 of 3 distinct risk level - low, medium, high. Each category will be treated according to a tailored treatment protocol:
We assume that personalized treatment of the disease, based on identifying risk factors will lower the number of patients with active disease.
1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.
This study's planned enrollment of 400 is above the median of 60 across 916 interventional studies indexed under Dental Caries.
Browse Dental Caries studies →Medical Corps, Israel Defense Force is the lead sponsor of 33 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: behavioral intervention
Behavioral: behavioral intervention
* Dietary instructions * Oral hygiene instructions: GC plaque indicator kit * Antibacterial therapy: medident sol. one week a month, for 6 months * Fluorides: VOCO Profluorid varnish, once every 3 month * Restoration * Follow ups
Improvement in one of the risk factors (such as eating habits, saliva, plaque control, fluorides).
Time frame: 6 months
Progression of the disease in 30% of patients in the control group in comparison to only 15% in the intervention group.
Time frame: 18 months
This study is status unknown, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical Corps, Israel Defense Force